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FIRST PATIENTS WITH 
HYPEKIMMUNOGLOBULINEMIA D SYNDROME FROM
THE UNITED STATES
In their article Grose et al.1 provide much needed informa­
tion on two patients with possible hyperimmunoglobulinemia 
D and periodic fever syndrome (HIDS). Thus far HIDS has 
mainly been diagnosed in European patients and no cases 
from the United States were known.2 From 1992 onward the 
International Hyper-IgD study group has maintained a case 
registry that collects the clinical data on all known HIDS 
patients to improve awareness of, facilitate diagnosis of and 
investigate novel therapies for this syndrome.2 Including the 
cases presented by Grose we now have accurate clinical data 
on 74 HIDS patients.
The clinical features of the described patients are charac­
terized by short bouts of periodic fever accompanied by skin 
lesions and arthralgias which might very well be compatible 
with HIDS. The diagnosis of HIDS is made on the basis of the 
clinical history and elevated serum IgD concentrations (>100 
units/ml).2 Although the clinical picture is compatible with 
HIDS, the reported IgD concentrations of these patients, 
being 15 mg/dl (106 units/ml) and 9 mg/dl (63 units/ml), are 
rather low. However, these values may underestimate the 
true figure because IgD is susceptible to spontaneous frag­
mentation during storage and shipping which interferes with 
the single radial immunodiffusion used to measure IgD.3
Of special interest is the occurrence of 2 cases in one 
family. Indeed HIDS appears to be a familial disorder with an 
autosomal recessive hereditary trait; thus far 12 families with
2 or more affected family members are known to us. Recently 
we have initiated efforts to localize the gene encoding for 
HIDS.4 We were able to exclude the gene causing familial 
Mediterranean fever (another periodic fever syndrome) as the 
primary disease locus for HIDS, but more families are needed 
to identify the HIDS gene.
Grose et al. suggest that the patient described in the initial 
report of IgG4 deficiency could suffer from HIDS because she 
had concomitant elevated IgD and IgA concentrations.
This patient, a 36-year-old Caucasian woman, suffered 
from recurrent infections of the upper and lower respiratory 
tract. In our opinion the diagnosis of HIDS in this patient is 
unlikely because HIDS patients do not present with recurrent 
infections and reported serum IgG4 concentrations are nor­
mal in these patients.2 Furthermore the combination of 
elevated serum IgD and IgA concentrations is not unique for 
HIDS but is also seen in other patients without HIDS.5
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IN REPLY:
I have reviewed the letter from Drs. Drenth and Weemaes 
from the Netherlands about the hyperimmunoglobulinemia D 
syndrome (HIDS).1,2 I concur with their initial remarks 
about the difficulty with making that diagnosis in the two 
siblings from Iowa. For that reason I personally followed the 
index case for 7 years to be assured that the diagnosis of 
HIDS was reasonable and that all alternative diagnoses had 
been excluded. Every attempt was made to adhere strictly to 
the criteria laid out by the European investigators. In that 
regard I note that Drenth et al.3 in a 1994 article outlined the 
following two major criteria for diagnosis of HIDS: “patients 
were included if they had a history of recurrent fever, defined 
as an elevation of body temperature above 38.5°C, and had a 
sustained elevated level of serum IgD above 6 mg/dl mea­
sured on two occasions with at least a one month interval.” In 
their definitive review of HIDS in European children and 
adults,2 they “could not detect a relationship between the 
level of the serum IgD (as long as it was elevated) and either 
the frequency or severity of attacks.”2
We excluded all diseases mentioned in the list of differen­
tial diagnoses from the European studies; many of these 
diseases or conditions are obvious, e.g. leprosy, tuberculosis, 
Hodgkin’s lymphoma, ataxia-telangiectasia, X-linked agam­
maglobulinemia and recipients of bone marrow transplants.4 
More recently the fourth edition of Immunologic Disorders in 
Infants and Children has been published, including a section 
on HIDS.5 After a perusal of that comprehensive textbook, I 
found no other known condition that explains the signs and 
symptoms carefully documented in the two children since 
1988.
In our review we included a section on IgD immunology 
because the functions of this immunoglobulin isotype remain 
largely unknown.1 Is it an evolutionary remnant or does it 
continue to play a role in regulation of human immunoglob­
ulin synthesis? In that regard we consider that our multiyear 
case analyses are instructive. In addition to an elevated IgD 
level, our index case had an extraordinarily high serum IgA 
level at age 3 years (893 mg/dl). Over the next 7 years the IgA 
level fell to <300 mg/dl. Also at age 3 years he had no 
detectable IgG4, but by age 9 it was detectable. A symptom­
atic sibling of the index case had elevated IgD and mildly 
elevated IgA. As a reminder, normal IgD levels (under 3 
mg/dl) are attained in early childhood.1 This insight into the 
natural history of HIDS suggests a broader defect in regula­
tion of immunoglobulin synthesis and switching with variable 
affects on isotype levels from patient to patient. Indeed 
elevated serum IgA levels remain an excellent marker for
HIDS.1,2
Since publication of the HIDS article in January 1996,1 1 
have received telephone consultations from physicians in 
Lincoln, Nebraska, Wichita, Kansas and Dallas, TX, In each 
instance the physicians described children with histories and 
laboratory findings compatible with HIDS. Therefore HIDS
